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The optimal method for respiratory muscle endurance (RME) assessment remains unclear. 
This study assessed the test-retest reliability of two RME-test methodologies. Fifteen healthy 
adults attended the laboratory on four occasions, separated by 5 ± 2 days, and completed each 
test in a random, “one on two” order. They performed spirometry testing, maximal respiratory 
pressure assessment and two different RME tests: an inspiratory resistive breathing (IRB) and 
an isocapnic hyperpnea endurance (IHE) test. Typical error, expressed as coefficient of 
variation, for IRB maximal inspiratory pressure (MIP) and IHE maximal ventilation were 
12.21 (8.85-19.67) % and 10.73 (7.78-17.29) %, respectively. Intraclass correlation 
coefficients for the same parameters were 0.83 (0.46-0.94) and 0.80 (0.41-0.93), respectively. 
No correlations were found between RME parameters derived from the IHE and IRB tests (all 
p>0.05). Significant positive correlations were found between both IRB and IHE outcomes 
and spirometry parameters, MIP and maximal expiratory pressure (p<0.05).  
Given these results, IRB and IHE appear to be suitable for RME testing in healthy people, 
although they may reflect different physiological mechanisms (respiratory mechanics and 
respiratory muscle capacity for IHE test vs. inspiratory muscle capacity for IRB test). Future 
studies are therefore warranted that compare IRB and IHE tests in clinical settings. 
 







Similar to other skeletal muscles, respiratory muscle function can be characterised by strength 
and endurance. Specifically, respiratory muscle strength (RMS) is the ability to produce a 
maximal force level and is usually estimated by maximal inspiratory and expiratory pressures 
(MIP and MEP, respectively). Respiratory muscle endurance (RME) is the ability to sustain a 
high level of work (i.e., ventilation) under isocapnic conditions (Leith, 1976) or to breathe for 
a prolonged period against a high resistive load (Jones et al., 1985). In clinical practice, 
respiratory muscle function is commonly assessed from MIP and MEP manoeuvres which are 
well-tolerated, reliable and can be compared to age- and sex-matched reference values (Black 
and Hyatt, 1969; Wilson et al., 1984). However, whilst a correlation between RMS and RME 
is suggested (American Thoracic Society/European Respiratory Society, 2002 statement), the 
exact relationship remains to be elucidated.  
Currently, MIP and MEP measurements are commonly used as an assessment of global 
respiratory muscle function (American Thoracic Society/European Respiratory Society, 2002 
statement; Lotters and Burdof, 2002). However, concerns have been raised regarding the 
clinical relevance of MIP and MEP. Specifically, maximal pressures are rarely required 
during daily living and the sensitivity of these assessments, and therefore their ability to detect 
early impairments in respiratory muscle function, is questionable. For instance, in the early 
stages of obstructive pulmonary diseases, a training-like effect on RMS is reported, with MIP 
and MEP remaining normal or even becoming superior to that observed in healthy people 
(Heinzmann-Filho et al., 2012; Similowski et al., 1991). This highlights the issues with 
interpreting changes, or the lack thereof, in maximal pressures with regards to respiratory 
health.  
Assessing RME is particularly relevant given its role in enabling ventilation and gas exchange 
during physical activities. Respiratory muscle fatigue has been shown following intensive 
whole-body exercise in healthy adults (Johnson et al., 1997; Verges et al., 2006) and can 
affect whole-body exercise performance through a respiratory metaboreflex (Dempsey et al., 
2006). Thus, evaluating RME may offer an alternative, useful tool with which to identify 
relevant early clinical changes in respiratory muscle function, though there is no consensus 
regarding the optimal methodology to assess RME (American Thoracic Society/European 
Respiratory Society, 2002 statement; Troosters et al., 2009). 
Consequently, the development of an incremental protocol, akin to the widely accepted Bruce 
protocol for exercise testing, has been investigated (American Thoracic Society/European 
Respiratory Society, 2002 statement). Specifically, while RME tests using an external load 
predominantly focus on the inspiratory muscles (inspiratory resistive breathing tests (IRB); 
(American Thoracic Society/European Respiratory Society, 2002 statement; Formiga et al., 
2018; Langer et al., 2013), ventilatory endurance tests or isocapnic hyperpnea tests  (IHE) 
involve both inspiratory and expiratory muscle loading by replicating hyperpnea as observed 
during intense whole-body exercise (American Thoracic Society/European Respiratory 
Society, 2002 statement; Bai et al., 1984; Mancini et al., 1994; Vincent et al., 2016). RME 
tests, both IRB and IHE, typically set their workload increments according to maximal 
voluntary ventilation (MVV) for IHE, or MIP for IRB. Indexes of RME are usually recorded 
from the last stage completed by participants and are expressed either in absolute values or 
relative to MVV or MIP (Clanton and Diaz, 1995; Nickerson and Keens, 1982; Verges et al., 
2009; Vincent et al., 2016). Given these methodological differences, it should be emphasized 
that IHE and IRB may assess different physiological mechanisms. Specifically, IHE provides 
outcomes related to respiratory muscles, lung and chest wall mechanics and can be under-
estimated, for instance, in obstructive respiratory disease patients (i.e., Chronic Obstructive 
Pulmonary Disease; COPD) due to an increased airway resistance and chest wall remodelling 
(thoracic distension; (Rochester and Arora, 1983). In contrast, IRB, which is used more 
frequently, has the advantage of being less influenced by airway resistance but relies on high-
intensity, low-speed contractions, which are significantly different from respiratory muscle 
contractions during spontaneous breathing.  
Despite several decades of investigation, the most appropriate method of assessing RME for 
routine clinical practice remains to be determined, as do the respective reliabilities of the IRB 
and IHE tests. Therefore, the primary aim of this study was to compare the outcomes from 
two distinct RME tests (IHE and IRB) and the test-retest reliability associated with such 
assessments in healthy young adults. The secondary aim was to ascertain the relationships 
between both RME testing outcomes and clinical parameters such as RMS, lung function and 
physical activity levels. 
 
2. Material and method 
2.1 Participants 
Following written informed consent, fifteen healthy adults (6 females; 25.7 ± 3.0 years) 
participated in the study. Ethical approval was granted by the local committee (CPP Grenoble 
Sud Est V) and the study was conducted in accordance with the Declaration of Helsinki. 
2.2 Study design 
Participant’s descriptive information is presented in Table 1. Briefly, they visited the 
laboratory on four separate occasions, separated by 5 ± 2 days, to complete each test in a 
random, “one on two” order. Specifically, in order to minimize a potential learning effect, a 
participant assigned to the IRB test during the first visit performed the IHE test for the second 
visit, then the IRB for the third and the IHE for the last visit. 
Prior to performing either RME test, lung function, respiratory muscle strength and physical 
activity levels were measured. Spirometry measurements were conducted according to 
standard procedures (Miller et al., 2005). Forced expiratory volume in 1 second (FEV1; 
FEV1%pred), forced vital capacity (FVC; FVC%pred) and MVV sustained for 12 seconds were 
measured (Medisoft, Dinant, Belgium) and reported in absolute and % of predicted values. 
Physical activity was assessed according to the three dimensions of the Baecke questionnaire 
(e.g., work, leisure and sport levels of physical activity (Baecke et al., 1982)). RMS was 
assessed by MIP and MEP (MicroRPM, Carefusion, San Diego, California, USA) according 
to the recommendations for respiratory muscle testing (American Thoracic Society/European 
Respiratory Society, 2002 statement), with the best of three reproducible values being 
recorded and expressed in absolute and % predicted values (Wilson et al., 1984). Perceived 
symptoms of breathlessness and respiratory muscle exertion were determined at task failure in 
all RME tests using the Borg scale (Borg, 1982).  
2.3 Respiratory muscle endurance 
2.3.1 Isocapnic hyperpnea endurance test (IHE) 
The IHE test was performed with the Spirotiger® (Idiag, Fehraltorf, Switzerland), a 
commercially available device used for respiratory muscle training that allows partial CO2 
rebreathing to ensure normocapnia during high ventilatory load (Verges et al., 2009; Villiot-
Danger et al., 2011). As previously described (Verges et al., 2009) and according to the latest 
recommendations (Laveneziana et al., 2019), IHE consists of an isocapnic hyperpnea test with 
increasing levels of minute ventilation until task failure. Participants were asked to breathe 
through a mouthpiece connected by a bi-directional valve to a rebreathing bag and ambient 
air. The volume of the bag was set at 50% of forced vital capacity (FVC) and breathing 
frequency was adjusted to obtain a minute ventilation (VE) corresponding to 30% MVV for 
the first stage. Subsequently, breathing frequency was increased every 3 minutes to increase 
VE by 10% MVV. Task failure was determined by the inability of the participant to sustain 
the VE level despite strong verbal encouragement. The Spirotiger® provided continuous audio 
feedback for breathing frequency and visual feedback to control tidal volume throughout the 
test. RME was determined as the last 3-min stage completed and expressed in maximal 
absolute VE and relative to MVV values (VEmax in L·min
-1 and VEmax in %MVV, respectively). 
The time to task failure was also recorded. 
2.3.2. Inspiratory resistive breathing test (IRB) 
The IRB test was performed using the Pro2® (Design Net, Smithfield, USA), which is 
commonly used for inspiratory muscle training and respiratory muscles assessment in both 
clinical and sports settings (Formiga et al., 2018; Formiga et al., 2019; Hursh et al., 2019). In 
this study, we used an incremental inspiratory test based on inspiratory repetitions with a 
resistance modulated by the inspiratory target pressure. The IRB involved a 3-s inspiration / 
5-s expiration with the level of inspiratory resistance increasing every 20 respiratory cycles. 
Participants were asked to inspire through a mouthpiece attached to the Pro2®, with 
exhalation performed outside the device. Prior to RME testing, MIP was determined using the 
Pro2® (MIPpro2); the first stage started at 30% MIPpro2 after which the load was increased by 
10% MIPpro2 every 20 inspirations. Task failure was defined as the inability to reach or sustain 
the MIP target for at least 1.5 seconds for three consecutive inspirations despite strong verbal 
encouragement. The Pro2® provided continuous visual feedback regarding the inspiratory 
pressure produced by the participants and the target pressure. RME was determined as the last 
stage of 20 inspirations completed and expressed in maximal absolute inspiratory pressure 
and relative to the MIPpro2 values (MIPmax in cmH2O and MIPmax in %MIPpro2, respectively). 
The time to task failure and the total number of inspirations were also recorded. 
2.4. Statistical analysis 
All variables are reported as mean (standard deviation (SD)). Normality was determined using 
Kolmogorov-Smirnov test. Paired t-tests or Wilcoxon tests and Pearson or Spearman 
correlations (according to normality) were used to detect systematic bias and the association 
between first and second sessions of each testing method (i.e., IHE1, IHE2 and IRB1, IRB2; 
(Atkinson and Nevill, 1998). Absolute reliability was evaluated according to typical error 
expressed as a coefficient of variation (CVTE; (Hopkins, 2000). Relative reliability was 
assessed by calculating intraclass correlation (ICC) using a two-way mixed-effects model for 
single measurement and absolute agreement following the online spreadsheet of Hopkins 
(2000, 2002). Bland-Altman plots were also used with 95% limits of agreement (LOA) to 
ascertain differences across the range of values produced between sessions for each RME 
assessment method (Bland and Altman, 1986). Pearson or Spearman correlations were 
calculated to investigate the association between the outcomes of IHE and IRB tests, RMS, 
lung function variables and physical activity index. A multiple linear regression model (i.e., 
stepwise regression) was conducted to identify relationship between parameters that account 
in the variation of RME variables (VEmax, MIPmax). Statistical procedures were performed on 
Statistica version 10 (Statsoft, Tulsa, OK) and SPSS version 25 (IBM corp, Armonk, NY), 




3.1 Comparisons of IHE and IRB outcomes 
One participant was unable to complete all four experimental sessions due to lack of time. 
Participants presented supra-normal RMS according to reference values (Wilson et al., 1984), 
a normal body mass index (22 ± 1.7 kg·m-2) and a normal lung function (Table 1). Moreover, 
all participants tolerated IHE and IRB tests well without any adverse effect.  
Individual performances during the last completed stage of the IRB test and the IHE test are 
shown in Figure 1. No difference was found between end-IHE and end-IRB maximal 
respiratory levels expressed in relative values (VEmax 60 ± 11 %MVV and MIPmax 67 ± 9 
%MIPpro2; p = 0.14) or between IRB and IHE end-exercise score of respiratory muscle 
exertion (p = 0.098). However, end-exercise breathlessness was higher (p < 0.001) and the 
time to task failure shorter (p = 0.046) during IHE compared to IRB. Sex differences were 
found for absolute values of FEV1, FVC and MVV, as well as absolute respiratory muscle 
strength (MIP and MEP) and endurance (MIPmax and VEmax). However, when expressed in 
relative values, all of these parameters except MVV were no longer different between sexes 
(Table 2). 
3.2 Between days reliability  
3.2.1 IHE test-retest 
Results of the IHE test-retest reliability are summarised in Table 3. During IHE1 and IHE2, 
participants reached similar absolute VEmax, corresponding to 60 ± 11 and 58 ± 8 %MVV (p = 
0.53). No systematic bias was detected between IHE1 and IHE2. Significant correlations were 
found between IHE1 and IHE2 for VEmax (r = 0.64; p = 0.01), but not for time to task failure 
(r = 0.52; p = 0.05).  With regard to absolute reliability, absolute VEmax demonstrated stronger 
CVTE agreement than time to task failure between IHE1 and IHE2. Highest relative reliability 
(i.e., ICC) was found for absolute VEmax. The corresponding Bland-Altman plots illustrating 
the agreement for absolute IHE VEmax and IHE time to task failure are shown in Figures 2A 
and 2B, respectively. 
3.2.2 IRB test-retest 
Results of the IRB test-retest reliability are summarised in Table 4. During IRB1 and IRB2, 
participants reached similar absolute MIPmax corresponding to 98.9 ± 19.7 and 94.2 ± 18.7 % 
MIPPro2, respectively. Systematic bias was detected for breathlessness sensation and time to 
task failure (p < 0.05). A significant correlation between IRB1 and IRB2 was found for 
absolute MIPmax (r = 0.72; p < 0.01), the total number of inspirations (r = 0.54; p = 0.04) and 
the time to task failure (r = 0.53; p = 0.04). Absolute reliability expressed with CVTE revealed 
that absolute MIPmax had a stronger agreement than the total number of inspirations and IRB 
time to task failure between IRB1 and IRB2. Highest relative reliability (i.e., ICC) was found 
for absolute MIPmax. The corresponding Bland-Altman plots illustrating the agreement for 
IRB absolute MIPmax and IRB time to task failure are shown in Figures 2C and 2D, 
respectively.  
3.3 Correlations between RME tests, lung function and physical activity 
No correlations were found between RME parameters derived from the IHE and IRB tests (all 
p > 0.05). Regarding IHE correlations, significant relationships were found between end-IHE 
absolute VEmax, MEP and lung function parameters (Figures 3A, 3B and 3C). Moreover, the 
multilinear regression model indicates that FVC and MVV accounted significantly in the 
variation of VEmax (R
2
 = 0.43 and 0.19, p < 0.05, respectively). Concerning IRB, significant 
correlations between end-IRB absolute MIPmax, MEP and absolute lung function parameters 
were also found (Figure 4A, 4B and 4C). A significant correlation was also found between 
end-IRB absolute MIPmax and the level of physical activity dimension “Sport index” (r = 0.54; 
p = 0.04). Furthermore, FVC accounted significantly in the variation of MIPmax (R




The current study aimed to determine the reliability of two distinct incremental RME testing 
methods (IHE and IRB) and to evaluate the relationships between RME outcomes and other 
physiological parameters (RMS, lung function and physical activity index) in healthy young 
adults. The main findings were that IHE and IRB reached a comparable level of reliability in 
terms of CVTE and ICC for absolute VEmax and MIPmax, the principal measures of interest.  
Previous studies using RME testing methods primarily focused on determining maximal 
outcomes in healthy participants. Specifically, by using an IRB test, Martyn et al. (1987) 
reported end-test maximal relative MIP values that were between 55 to 75% of MIP at 
baseline, comparable to the 67 ± 9 %MIPmax in the present study. By using an IHE test, 
Vincent et al. (2016) reported a higher end-test maximal relative ventilation (74 ± 17 %MVV) 
in comparison to the present study (60 ± 11 %MVV). Such a discrepancy could be explained, 
at least in part, by the use of an estimated MVV in Vincent et al. (2016) to predict a target VE 
for each test. This may have underestimated VE and, therefore, overestimated the maximal 
outcome of the IHE test. This therefore emphasizes the need for rigorous baseline 
measurements of MIP and MVV parameters for subsequent use in IRB and IHE testing 
protocols. Indeed, MIPpro2 demonstrated excellent absolute and relative reliability, which is in 
accordance with previous findings that reported maximum static respiratory pressures 
assessed with a portable device to be both precise and reproducible (Hamnegard et al., 1994). 
This also highlights the potential utility of the Pro2® device to provide an index of inspiratory 
strength, in addition of RME.  
Our two principal measures of interest, absolute MIPmax and VEmax, demonstrated the highest 
test-retest relative reliability between IHE1-IHE2 and IRB1-IRB2, with no systematic bias. 
Moreover, correlations revealed good relationships between IHE1-IHE2 and IRB1-IRB2. 
However, only a modest absolute reliability was found for VEmax and MIPmax, with a CVTE 
higher than 7% CVTE (Atkinson and Nevill, 1998). Whilst the mean difference between IRB1 
and IRB2 MIPmax was only -3.5 cmH2O, in a subset of three participants, a greater drop 
ranging from 21 to 31 cmH2O was found. Regarding the IHE test, there was one participant 
with a drop of 44 L·min-1 between IHE1 and IHE2, compared to the average difference of 3.2 
L·min-1 between tests. The explanation for this large intra-individual variability in these 
participants is unclear but may be related, at least in part, to motivational issues to perform the 
same test twice.  
Previous studies have assessed the reliability of RME testing methods similar to the current 
IRB test in healthy participants and patients with respiratory diseases (Enright et al., 2006; 
Formiga et al., 2018; Hart et al., 2002; Larson et al., 1999; Romer and McConnell, 2004). 
However, there are key methodological differences between the RME assessments and 
reliability index used in these previous studies that prevent a direct comparison to these 
results. Firstly, previous reliability studies have not considered isocapnic hyperpnea RME 
assessment. Larson et al. (1999), Hart et al. (2002) and Romer and McConnell (2004) studied 
RME reliability of threshold loading apparatus in COPD and healthy participants, reporting 
considerable variability in the reliability. Specifically, whilst Larson et al. (1999) reported a 
greater reliability than in the present study, Hart et al. (2002) observed a significantly lower 
reliability. Differences in sample size and the number of repeats in the test-retest design limit 
inter-study comparisons, as well as the inter-test period which was as much as 78 ± 82 days in 
Hart et al. (2002). Furthermore, methodological discrepancies with regards to controlling 
breathing patterns and the amalgamation of multiple independent studies with separate 
research questions to investigate the reliability are important elements to be considered in the 
interpretation of earlier studies. In COPD, Formiga et al. (2018) reported higher reliability 
than observed in the current study, with ICC of 0.99 for their primary outcome measure 
(SMIP: sustainable maximal inspiratory pressure). A key difference in the testing protocol, 
however, was that the test-retest sessions were on the same day in Formiga et al. (2018), 
which may impact reliability simply by decreasing heterogeneity and, consequently, affect the 
ICC results (Atkinson and Nevill, 1998). Nevertheless, one should acknowledge that 
reliability was moderate in the present study for both IHE and IRB tests. Differences in RME 
outcomes (assessments and reliability index) reported in the present study highlight that, 
despite multiple ways available to test the reliability in sport and exercise field, the optimal 
test applicable across different populations (i.e., healthy, COPD, etc.) is not clear. In this way, 
our study presents the first results of reliability regarding respiratory muscle assessment with 
IHE methods. Future research should extend this work to respiratory disease patients. 
Familiarization sessions may also be required in order to achieve greater reliability when 
using these kinds of RME testing methods, which are complex to learn within a single 
session. Nonetheless, significant correlations between maximal outcomes from both IRB and 
IHE and lung function parameters were found, indicating that those with larger lung volumes 
and able to produce higher maximal expiratory flow rates are also able to reach higher VEmax 
and MIPmax during RME tests. Conversely, it can be expected that patients with impaired lung 
function will show reduced RME, although further studies evaluating RME in patients are 
required. Moreover, while correlations between RME outcomes and lung function may have 
been limited in the present study due to only healthy young participants with relatively 
homogenous spirometric values were evaluated, correlations between RME outcomes and 
lung function might be stronger in patients with more heterogeneous spirometric values (e.g., 
COPD of various severities).  
RME outcomes (VEmax and MIPmax) also correlated with RMS (MEP only for IHE) showing 
some relationship between respiratory muscle endurance and strength, although these aspects 
of RM function are not equivalent. MIPmax during IRB also correlated with the sport physical 
activity dimension, possibly because higher physical activity levels (especially sport) may 
increase muscle strength and endurance, including RMS. Moreover, we found based on 
stepwise regression that FVC was the best predictor of RME performance, at least when 
considering absolute VEmax and MIPmax during the IHE and IRB tests, respectively. 
Sensations of respiratory muscle exertion reported at exercise cessation were not different 
between IHE and IRB, while breathlessness perception was significantly higher in IHE. The 
continuous production of high respiratory flow rates as required during IHE may induce 
greater breathlessness than repetitive inspiratory efforts at high inspiratory pressures and low 
flow rates. Conversely, although the difference in RM exertion between IRB and IHE did not 
reach significance (p = 0.09), the IRB test tended to induce higher sensations of RM exertion, 
probably due to the high resistance participants had to overcome. Altogether, despite IRB and 
IHE being maximal tests requiring intense effort from participants, they appear to be well-
tolerated in healthy people. The slight differences regarding participant’s sensations between 
both testing procedures underline that IRB and IHE probably evaluate distinct respiratory 
mechanisms. This hypothesis is supported by the lack of correlation between the outcomes of 
the IRB and IHE tests. This suggests that, despite both tests being designed to evaluate RME, 
the characteristics of the IHE and IRB tests differ significantly (e.g., respiratory muscle group 
recruited, type of contraction), leading to different outcomes. 
The IHE test is known to require high levels of ventilation that imitate ventilatory efforts 
during whole body exercise (Rochester and Arora, 1983). Interestingly, the present study 
found that the IRB test reflected more associations with other respiratory function and 
physical activity parameters than IHE, despite daily living not requiring people to produce 
elevated inspiratory pressure. In this regard, the present results highlight that an IRB method 
only based on a specific muscular group (i.e., inspiratory muscle) may be sufficient to 
represent the whole respiratory muscle function in healthy participants. Moreover, it is 
assumed that IRB reduces the contribution of respiratory mechanics in RME assessment 
compared to IHE because no ventilatory output is required in such testing. Therefore, IRB 
may provide better outcomes in pulmonary obstructed patients than the IHE method, in 
comparison to healthy peers due to its methodology based on repetitive inspiratory 
contraction which is less sensitive to ventilatory output than IHE (American Thoracic 
Society/European Respiratory Society, 2002 statement). This emphasises the need to extend 
the present results to other populations, such as obstructive respiratory diseases, in order to 
further promote the evaluation of RME in various settings (sport, research, clinical settings). 
It should be acknowledged that the present study did not assess participants’ affinity with 
each testing method. Nonetheless, participants reported anecdotally that Pro2® device was 
preferable in terms of providing clearer feedback compared with the Spirotiger®, making the 
exercise protocol easier for participants and the experimenter. Furthermore, it is important to 
acknowledge that the present study only incorporated two test-retest sessions for each method 
(IHE and IRB), which may have impacted on reproducibility outcomes. Future studies should 
therefore consider multiple repeat sessions to verify our findings. 
 
5. Conclusion 
This is the first study to compare the reliability and clinical associations of two different 
methods of RME assessment. Despite comparable test-retest reliability and no differences 
between the maximal relative criteria provided by both RME testing methods, IHE and IRB 
outcomes were not related to each other and showed distinct correlations with clinical 
markers. In this study, VEmax during IHE and MIPmax during IRB were the best performance 
indicators regarding RME capacity of the participants as supported by the best scores of 
reliability and the stronger relationships with clinical markers. In order to improve reliability, 
an initial familiarization session would be advised. Further studies are also required to 
evaluate reliability and compare both IRB and IHE testing methods in clinical setting (e.g., in 
patients with respiratory diseases). 
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8. Figure legends 
 
Figure 1. 
Individual performances expressed as a percentage of maximal voluntary ventilation or 
maximal inspiratory pressure attained on the incremental test for each method: Isocapnic 
hyperpnea endurance (IHE) and Inspiratory resistive breathing (IRB). 
 
Figure 2.  
Bland-Altman plots of difference vs. mean of the two isocapnic hyperpnea endurance tests 
(IHE; panels A and B) and inspiratory resistive breathing tests (IRB; panels C and D) for 
absolute minute ventilation (VEmax in L·min
-1 panel A), IHE time to task failure in minutes 
(panel B), IRB absolute maximal inspiratory pressure (MIPmax in cmH2O, panel C) and IRB 
time to task failure in minutes (panel D). 
 
 
Figure 3.  
Relationship between isocapnic hyperpnea endurance test (IHE) and lung function 
parameters: absolute maximal minute ventilation (VEmax) and absolute forced vital capacity 
(FVC, panel A), maximal expiratory pressure (MEP, panel B) and absolute maximal 
voluntary ventilation (MVV, panel C). 
 
Figure 4. 
Relationship between inspiratory resistive breathing test (IRB) and lung function parameters: 
absolute maximal inspiratory pressure (MIPmax) and absolute forced vital capacity (FVC, 
panel A), maximal expiratory pressure (MEP, panel B) and absolute maximal voluntary 





9. Tables  
 









































volume in one second; FVC, forced 
vital capacity; MVV, maximal 
voluntary volume; MIP, maximal 




Characteristics   
Age (y) 25.7 ± 3.0 
Height (cm) 172.8 ± 9.4 
Weight (kg) 65.9 ± 7.0 
  
Physical Activity Index   
Usual PA index 2.5 ± 0.5 
Sport PA index 3.8 ± 0.7 
Leisure PA index 3.4 ± 0.8 
Global PA index 9.8 ± 1.6 
Lung function   
FEV1 (L) 4.2 ± 0.8 
FEV1 (%) 103.4 ± 9.0 
FVC (L) 4.8 ± 0.9 
FVC (%) 99.8 ± 8.6 
MVV (L) 182.8 ± 32.1 
MVV (%) 119.9 ± 23.8 
Respiratory muscle strength  
MIP (cmH20) 120.7 ± 32.5 
MIP (%pred) 122.8 ± 27.6 
MEP (cmH2O) 164.1 ± 37.2 
MEP (%pred) 125.9 ± 19.2 






















Values are means ± SD. FEV1, forced expiratory volume in one second; FVC, forced vital capacity; MVV, 
maximal voluntary ventilation; MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure. VEmax, 
maximal ventilation minute during IHE test; MIPmax, maximal inspiratory pressure during IRB test. P values are 
* for p < 0.05 and ** for p < 0.01.  
Lung function Males (N = 9) Females (N= 6) 
FEV
1
 (L) 4.7 ± 0.5 3.5 ± 0.3** 
FEV
1
 (%) 101.3 ± 9.1 106.5 ± 8.5 
FVC (L) 5.4 ± 0.6 3.9 ± 0.4** 
FVC (%) 97.3 ± 9,5 103.5 ± 6.0 
MVV (L) 200.7 ± 26.5 156.0 ± 17.8* 
MVV (%) 106.0 ± 16.1 140.7 ± 17.5* 
Respiratory muscle strength 
MIP (cmH
2
O) 135.7 ± 32.3 98.2 ± 16.9* 
MIP (%pred) 117.0 ± 28.0 131.4 ± 27.0 
MEP (cmH
2
O) 188.3 ± 23.3 127.8 ± 19.1* 
MEP (%pred) 119.9 ± 14.7 134.9 ± 23.1 





) 125.3 ± 26.9 73.3 ± 19.9* 
V
E
max (%MVV) 62.2 ± 10.9 51.7 ± 14.7 
MIPmax cmH
2
O 92.9 ± 21.9 76.7 ± 14.9* 
MIPmax (%MIP
pro2
) 63.3 ± 10.0 68.3 ± 13.3 
 
Table 3. Between-days reliability of parameters measured during the IHE test 
 
Values are means ± SD; IHE1 and IHE2: first and second isocapnic hyperpnea endurance tests; change in the 
mean are expressed in percentage of mean values; CV
TE
: typical error expressed as a coefficient of variation; 
ICC: intraclass correlation coefficient; 95% CI: 95% confidence interval; V
E
max: maximal minute ventilation; 





 IHE 1 IHE 2 
Mean Change 
(95% CI) 
CVTE  (95% CI) ICC (95% CI) 
VEmax (L·min-1) 110.7 ± 32.3 107.5 ± 27.4 -3.21 (-12.77-6.35) 10.73 (7.78-17.29) 0.80 (0.41-0.93) 
 
Time to task failure (min) 11.8 ± 3.7 12.4 ± 2.8 0.61 (-1.28-2.49) 19.09 (13.80-30.74) 0.67 (0.03-0.89) 
Breathlessness sensation 14.2 ± 3.8 13.7 ± 3.0 -0.43 (-2.43-1.57) 17.43 (12.64-28.24) 0.67 (0.03-0.89) 
RM exertion 11 ± 4.3 11.1±3.3 0.14 (-1.93-2.22) 22.88 (16.58-36.85) 0.72 (0.14-0.91) 
      





Values are means ± SD; IRB1 and IRB2: first and second inspiratory resistive breathing endurance tests; change 
in the mean are expressed in percentage of mean values; CV
TE
: typical error expressed as a coefficient of 
variation; ICC: intraclass correlation coefficient; 95 % CI: 95% confidence interval; MIP
pro2
: maximal 
inspiratory pressure measured at baseline with Pro2® device; MIP
max
: maximal inspiratory pressure; RM: 

























 IRB 1 IRB 2 
Mean Change 




 (95% CI) 
MIPpro2 135.1 ± 29.2 135 ± 22.9 0.07 (-7.51-7.37) 6.75 (4.90-10.87) 0.94 (0.80-0.98) 
Number of inspirations 98.9 ± 19.7 94.2 ± 18.2 -4.64 (-15.12-5.83) 13.3 (9.64-21.42) 0.70 (0.08-0.90) 
MIPmax (cmH2O) 89.6 ± 17.2 86.1 ± 21.9 -3.49 (-12.24-5.27) 12.21 (8.85-19.67) 0.83 (0.46-0.94) 
Time to task failure (min) 15.3 ± 2.6 13.0 ± 2.8 -2.32 (-3.83-0.81) * 13.03 (9.44-21) 0.69 (0.03-0.90) 
Breathlesness sensation 8.4 ± 2.7 10.9 ± 3.8 2.50 (0.73-4.27) * 22.5 (16.35-36.25) 0.73 (0.15-0.91) 
RM exertion 12.7 ± 3.4 14.4 ± 3.0 1.71 (-0.24-3.67) 17.57 (12.72-28.31) 0.62 (-0.05-0.88) 
Figure 1 
 
 
Figure 2 
 
Figure 3 
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